Medical visa to India for patients from Afghanistan

Medical visa to India for patients from Kabul, Afghanistan. Patients travelling to Delhi, India for treatment to connect with +91 96 1588 1588 for details.

Share This Post

Some facts about medical visas to India for patients from Afghanistan. There are a huge number of patients travelling to India for medical treatment from Afghanistan.

  • CancerFax  helps in getting a medical visa. A visa is granted for up to one year with triple entries, provided that registration is required after the patient reaches the country.
  • If one seeks medical treatment in top specialized/recognized  hospitals in India,.
  • Up to  two attendants can accompany the patient who are closely related with him/her under separate attendant visas, whose visa validity will be the same as the medical visa

Serious ailments like neurosurgery; ophthalmic disorders; heart – related problems; renal disorders; organ transplantation; congenital disorders; gene therapy; radio therapy; plastic surgery; joint replacement, etc. will be of primary consideration.

Visa for Afghan Nationals

Eligibility Conditions and Supporting Documents for Different Visa Categories:

All visa applications should be accompanied by copy of personal particular page of the passport.
Visa applicants are required to submit own bank statement proving financial ability to pay all costs of the trip. In case of minor applicant (aged 15 and below) or a dependent, if they do not have individual bank account then they can submit bank statement of their parents/ spouse/ children.

Medical Visa

Documents required Duly completed Visa form with 2 photographs (2’x2’), original ID (Taskara) and its photocopy, original medical papers and its photocopy, confirmed return air ticket. Photocopy of medical papers pertaining to last visit on Medical Visa may also be submitted. For medical treatment/check up for a longer and regular period, a letter from Indian Doctor/hospital must be enclosed.
Processing period          4-5  working days
Fee: Gratis

The link for Indian medical visa application is given below

https://indianvisaonline.gov.in/

Contact Details of Indian High Commission and Consulates in Afghanistan
Details of Indian Embassies / High Commissions / Consulates in Afghanistan (Location, Contact Details including website link) is mentioned below:
1) India Embassy Afghanistan

Address Malalaiwat, Shar-e-Naw, Kabul Afghanistan
Phone +873-763-095560
+932-022-00185
Fax +873-763-095561
Email embassy@indembassy-kabul.com
Website URL www.meakabul.nic.in

2) India Consulate Afghanistan

Address Ameriat Cross Road, Near AbBakhsh Badmerghan Herat Afghanistan
Phone +934-022-2653
+934-022-1145
+934-025-7045
Fax +934-025-0032
Email cg.herat@mea.gov.in
cgiherat@yahoo.co.in
hoc.herat@mea.gov.in
Website URL www.meakabul.nic.in

3) India Consulate Afghanistan

Address Darwaza-e-Balkh Mazar-e-Sharif Afghanistan
Phone +937-020-20268
+937-979-29515
Fax +934-025-0032
Email cg.mesharif@mea.gov.in hoc.mesharif@mea.gov.in
Website URL www.meakabul.nic.in

4) India Consulate Afghanistan

Address Shahr-e-Nau, District 6, Kandahar-Herat Road, Kandahar Afghanistan
Phone +933-075-3011512
+933-075-3010874
+933-075-3011525
+933-075-3011512
+933-075-3010874
Email cg.kandahar@mea.gov.in cons.kandahar@mail.nic.in hoc.kandahar@mea.gov.in
Website URL www.meakabul.nic.in

5) India Consulate Afghanistan

Address Ilaka No.2, Habibabad, Jalalabad Afghanistan
Phone +937-560-03162
Fax +873-763-096147
Email cg.mesharif@mea.gov.in hoc.mesharif@mea.gov.in
rajeev.ifs@gmail.com
Website URL www.meakabul.nic.in

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Risk of developing secondary tumors following CAR-T cell therapy is minimal - A Stanford Study
CAR T-Cell therapy

Risk of developing secondary tumors following CAR-T cell therapy is minimal – A Stanford Study

CAR-T cell therapy, a groundbreaking cancer treatment, carries a risk of developing secondary tumors. This occurs due to the therapy’s potential to cause genetic mutations or alter the immune system’s regulation. Secondary malignancies can arise from these changes, presenting a significant long-term risk for patients. Continuous monitoring and research are crucial to understanding and mitigating these risks, ensuring safer outcomes for those undergoing CAR-T cell therapy.

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy